Our voluntary Board of Directors provides governance oversight and vision for the organisation.
Professor Maria Kavallaris (Co-Chair)
Maria Kavallaris BAppSc PhD is a nationally and internationally recognised cancer researcher. She is Head of the Tumour Biology and Targeting rogram at the Children’s Cancer Institute, and is a Director of the Australian Centre for NanoMedicine, UNSW Australia.
Leon Beswick (Co-Chair)
Leon Beswick is Managing Director of Civic Health. He has over ten years experience in implementing successful health communication campaigns for major pharmaceutical and biotech companies, as well as professional associations and health technology organisations .
Andrew Goodsall (Treasurer)
Andrew Goodsall BA (Hons) Grad Dip (Asian studies) MBA is is the senior healthcare analyst with MST Marquee Australia. Andrew has specialised in equity research since 1999, and is rated as the number one sector analyst in each of the major surveys since 2004. Prior to joining MST Marquee in 2017, he was with UBS and Citi.
Professor Suresh Mahalingam
Suresh Mahalingam BSc (Hons), PhD is a leading Australian virologist and international leader in viral inflammatory disease. His basic research.
Professor Ronika Power
Professor Ronika Power studies ancient human remains to understand what it was like to live – and die – in the past, and to communicate the science of human health, climate change, violence and mass migrations.
Professor Sandra Orgeig
Sandra Orgeig (BSc (Hons), PhD) joined the board in 2019 and is Professor in Pulmonary Biology and Associate Head of School (Research) in the School of Pharmacy & Medical Sciences at the University of South Australia.
Doctor Sarah Meachem
Doctor Sarah Meachem, PhD Monash University joined the Board in 2016 and is an academic research scientist and health research advocate. She completed her PhD at Monash University in 1999 where she studied reproduction.